SCHEMBL4155698

SCHEMBL4155698

COc1ccc(CNC(=O)N(C)c2ccc(SC(F)(F)F)cc2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 2/20 0.44
EPHX2 P34913 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
GAA P10253 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HPGD P15428 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
HTT P42858 1/20 0.40
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145579 0.89 ROCK2 (0.48) EPHX2ALDH1A1MEN1KMT2AHPGD
SCHEMBL4144739 0.87 MAPT (0.46) PTPRZ1EPHX2NR1H4ALDH1A1MEN1
SCHEMBL4144820 0.82 PTPRZ1 (0.35) PTPRZ1EPHX2NR1H4GAAHTT
SCHEMBL4157346 0.82 HPGD (0.47) GAAALDH1A1HDAC1MEN1KMT2A
SCHEMBL13774610 0.81 PTPRZ1 (0.39) PTPRZ1EPHX2NR1H4ALDH1A1KMT2A
SCHEMBL4142022 0.81 PTPRZ1 (0.37) PTPRZ1EPHX2NR1H4ALDH1A1HTT
SCHEMBL13774526 0.81 MCHR1 (0.37) PTPRZ1EPHX2NR1H4ALDH1A1KMT2A
SCHEMBL4154163 0.80 KMT2A (0.44) GAAALDH1A1MEN1KMT2AHTT
SCHEMBL4150851 0.80 PTPRZ1 (0.36) PTPRZ1EPHX2NR1H4GAAALDH1A1
SCHEMBL4145099 0.80 KMT2A (0.34) PTPRZ1EPHX2NR1H4ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 PTPRZ1 1175/4885EPHX2 2013/4885NR1H4 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.